LFTD Partners Inc. (LIFD) stock
LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
LFTD Partners r&d expenses
Research and development expenses are spending on new products and technology.
LFTD Partners's R&D Expenses for the twelve months ending Dec 31, 2023 was $19.80K, up 0.0% year over year. For fiscal 2023 it was $19.80K, up 0.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $19.80K | 0.0% |
| FY2022 | Dec 31, 2022 | $19.80K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $19.80K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
See a number that looks wrong?